logo-loader
viewe-Therapeutics PLC

e-therapeutics Chairman Mortazavi takes over CEO duties, 'solving a big unmet need in the industry'

e-therapeutics PLC's (LON:ETX) Chairman Ali Mortazavi talks to Proactive London about taking over CEO duties.

Mortazavi, formerly the boss of Silence Therapeutics, took over the helm at e-therapeutics after doing extensive due diligence on the company’s drug discovery platform.

The company has a computer-based platform to assist in drug discovery and Mortazavi believes it has established a key position among the small vanguard of companies across the globe applying computational biology to drug discovery.

Quick facts: e-Therapeutics PLC

Price: 13.5 GBX

AIM:ETX
Market: AIM
Market Cap: £56.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics PLC named herein, including the promotion by the Company of e-Therapeutics PLC in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 makes early rally as airline losses set to total...

Headlines from the Proactive UK newsroom. The FTSE 100 rallied early on after two days of losses with travel groups leading the way. The blue-chip index was up 30 points at 6,366. Airline losses will total around US$84bn this year according to the International Air Transport Association....

on 10/6/20

2 min read